Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25935950 | 1.00 | SHBG (0.34) | SHBGSMYD3 | |
| SCHEMBL2404767 | 1.00 | SHBG (0.34) | SHBGSMYD3 | |
| SCHEMBL8840566 | 1.00 | SHBG (0.34) | SHBGSMYD3 | |
| SCHEMBL8675545 | 0.87 | SHBG (0.42) | SHBG | |
| SCHEMBL1193150 | 0.87 | — | — | |
| SCHEMBL521520 | 0.86 | SMYD3 (0.45) | SHBGSMYD3 | |
| SCHEMBL23912364 | 0.86 | SHBG (0.32) | SHBG | |
| SCHEMBL10292125 | 0.81 | SMYD3 (0.33) | SMYD3 | |
| SCHEMBL2409982 | 0.81 | SMYD3 (0.33) | SMYD3 | |
| SCHEMBL12507920 | 0.81 | SMYD3 (0.30) | SMYD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240425445-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & CO (US) | 2024-12-26 | — | — | US | disclosed |
| US-12084401-B2 | Trisamide compounds and compositions comprising the same | MILLIKEN & COMPANY (US) | 2024-09-10 | — | — | US | disclosed |
| EP-4073164-B1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & CO (US) | 2024-05-22 | — | — | EP | disclosed |
| CN-117756662-A | Triamide compound and composition comprising same | 美利肯公司 | 2024-03-26 | — | — | CN | disclosed |
| EP-4332088-A2 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | Milliken & Company (US) | 2024-03-06 | — | — | EP | disclosed |
| CN-115066462-B | Triamide compound and composition comprising same | 美利肯公司 | 2024-01-09 | — | — | CN | disclosed |
| US-20230312460-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & COMPANY | 2023-10-05 | — | — | US | disclosed |
| US-11685732-B2 | MYST family histone acetyltransferase inhibitors | Epizyme, Inc. (US) | 2023-06-27 | — | — | US | disclosed |
| US-11667603-B2 | Trisamide compounds and compositions comprising the same | MILLIKEN & COMPANY (US) | 2023-06-06 | — | — | US | disclosed |
| EP-4073164-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | Milliken & Company (US) | 2022-10-19 | — | — | EP | disclosed |
| CN-115066462-A | Triamide compounds and compositions comprising the same | 美利肯公司 | 2022-09-16 | — | — | CN | disclosed |
| US-20210179544-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & COMPANY | 2021-06-17 | — | — | US | disclosed |
| WO-2021119632-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & COMPANY (US) | 2021-06-17 | — | — | WO | disclosed |
| US-5650417-A | Substituted pyridines, their preparation, and their use as pesticides and fungicides | HOECHST SCHERING AGREVO GMBH (DE) | 1997-07-22 | — | — | US | disclosed |
| EP-0719255-A1 | SUBSTITUTED PYRIDINES, PROCESS FOR PRODUCING THEM AND THEIR USE AS PESTICIDES AND FUNGICIDES | Hoechst Schering AgrEvo GmbH (DE) | 1996-07-03 | — | — | EP | disclosed |
| WO-1995007890-A1 | SUBSTITUTED PYRIDINES, PROCESS FOR PRODUCING THEM AND THEIR USE AS PESTICIDES AND FUNGICIDES | HOECHST SCHERING AGREVO GMBH (DE) | 1995-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667603-B2 | Trisamide compounds and compositions comprising the same | PTAR1, TIPRL, TCOF1 | SHBG 4534/4885SMYD3 1743/4885 |
| US-12084401-B2 | Trisamide compounds and compositions comprising the same | PTAR1, TIPRL, TCOF1 | SHBG 4534/4885SMYD3 1743/4885 |
| US-20240425445-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | PTAR1, TIPRL, TCOF1 | SHBG 4534/4885SMYD3 1743/4885 |
| US-20230312460-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | PTAR1, TIPRL, TCOF1 | SHBG 4534/4885SMYD3 1743/4885 |
| US-20210179544-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | PTAR1, TIPRL, TCOF1 | SHBG 4534/4885SMYD3 1743/4885 |
| US-11685732-B2 | MYST family histone acetyltransferase inhibitors | EP300, KAT2A, KAT6A | SHBG 4301/4885SMYD3 191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.